Akili, Inc. (AKLI)
Jul 2, 2024 - AKLI was delisted (reason: acquired by Virtual Therapeutics)
0.4331
+0.0010 (0.25%)
Inactive · Last trade price on Jul 1, 2024

Akili Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
1.951.680.320.543.94
Revenue Growth
426.49%419.50%-39.96%-86.34%-
Gross Profit
1.090.86-0.120.183.52
Operating Income
-56.23-64.49-90.68-60.72-25.44
Net Income
-48.55-59.49-19.04-126.66-25.65
Earnings Per Share
-0.61-0.76-0.64-91.88-22.20
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
63.3475.46136.4477.218.86
Total Debt
13.5915.4919.966.423.39
Net Cash (Debt)
49.7559.97116.4770.7815.47
Net Cash Growth
-49.13%-48.51%64.55%357.69%-
Net Cash Per Share
0.630.773.9051.3513.39

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-48.77-57.87-83.52-53.98-24.55
Capital Expenditures
-0.37-0.14-0.04-0.49-0.12
Free Cash Flow
-49.14-58.01-83.56-54.47-24.67
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
56.11%51.19%-36.53%34.01%89.44%
Operating Margin
-2886.60%-3842.97%-28073.37%-11286.06%-645.75%
Pretax Margin
-2489.32%-3542.31%-2459.75%-11402.97%-651.05%
Profit Margin
-2492.04%-3545.47%-5894.43%-23542.19%-651.08%
FCF Margin
-2522.33%-3457.09%-25870.90%-10125.28%-626.22%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020
Period EndingOct '26 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
17.5022.73270.15588.60-